Gateway Blog

Gateway Blog

New Startup Races to Develop Universal Test to Detect All Cancers

By Admin at 23 Mar 2016

GRAIL, an aptly named startup company launched by biotech company Illumina (the same company that has made DNA sequencing affordable and efficient) is setting out to achieve one of the Holy Grails that cancer doctors and researchers have been looking for – a blood test that could detect all cancers.

0 comments posted

    Categories

    Archive

    2018 2017 2016 2015
    99 cents of every dollar received directly funds cancer clinical trials

    58

    Current Gateway-funded clinical trials

    150+

    Clinical trials funded at leading institutions worldwide

    $16.56

    Funds one patient for one day at a Gateway-funded clinical trial

     
     

    Mission Partners